October 10, 2025

Definitive Healthcare Corp. (DH) Stock Analysis: Unveiling a 47.32% Potential Upside

Definitive Healthcare Corp. (NASDAQ: DH) presents a compelling opportunity for investors seeking exposure to the healthcare sector’s information services niche. With a market capitalization of $320.59..

Xencor, Inc. (XNCR) Stock Analysis: Exploring a 95.60% Potential Upside in the Biotech Sector

Xencor, Inc. (NASDAQ: XNCR), a dynamic player in the biotechnology industry, is garnering significant attention from investors due to its innovative approach in developing engineered monoclonal..

Collegium Pharmaceutical, Inc. (COLL) Stock Report: A 34.3% Potential Upside with Strong Buy Ratings

Collegium Pharmaceutical, Inc. (NASDAQ: COLL), a prominent player in the healthcare sector specializing in pain management medications, is currently capturing investor attention with its significant potential..

Vir Biotechnology, Inc. (VIR) Stock Analysis: A 185% Upside Amidst Biotech Challenges

Vir Biotechnology, Inc. (NASDAQ: VIR) has captured investor attention with its notable potential upside of 185.14%, making it a compelling consideration for those interested in the..

iRadimed Corporation (IRMD) Stock Analysis: Healthcare Innovator with Strong Revenue Growth and High RSI

iRadimed Corporation (NASDAQ: IRMD), a prominent player in the medical devices industry, is capturing investor attention with its innovative MRI-compatible medical products and robust financial performance...

Sionna Therapeutics, Inc. (SION): A 34% Upside Amid Biotech Innovations

Sionna Therapeutics, Inc. (SION), a dynamic player in the healthcare sector, is making significant strides in the biotechnology industry. With a focus on developing transformative treatments..

Dianthus Therapeutics, Inc. (DNTH) Stock Report: A Strategic Look at Its 78% Potential Upside

Dianthus Therapeutics, Inc. (NASDAQ: DNTH), a pioneering name in the biotechnology sector, is grabbing investor attention with its impressive 78.30% potential upside. This clinical-stage biotech company,..

CorMedix Inc. (CRMD) Stock Analysis: A Biotech Powerhouse with 86% Upside Potential

CorMedix Inc. (CRMD), a dynamic player in the biotechnology sector, is capturing investor attention with its promising financial metrics and significant upside potential. With a market..

Cogent Biosciences, Inc. (COGT): Analyst Ratings Point to a Promising 30% Upside

Investors eyeing the biotechnology sector may want to consider Cogent Biosciences, Inc. (NASDAQ: COGT), a company that has recently captured attention with its strong analyst ratings..

Eton Pharmaceuticals, Inc. (ETON) Stock Analysis: Unveiling a 47.93% Potential Upside in Rare Disease Market

Eton Pharmaceuticals, Inc. (NASDAQ: ETON) is making waves in the healthcare sector with its strategic focus on rare diseases. As a specialty and generic drug manufacturer..

Tyra Biosciences (TYRA) Stock Analysis: Unpacking the 131% Potential Upside for Biotech Investors

Tyra Biosciences, Inc. (NASDAQ: TYRA) is capturing significant attention in the biotechnology sector, not just for its cutting-edge research but also for its robust stock potential...

ArriVent BioPharma, Inc. (AVBP) Stock Analysis: A Promising 87% Upside in the Biotech Sector

ArriVent BioPharma, Inc. (AVBP), a burgeoning player in the biotechnology sector, has captured the attention of investors with its promising clinical pipeline and a potential upside..

Day One Biopharmaceuticals, Inc (DAWN) Stock Analysis: Exploring a 216% Potential Upside

Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) is making waves in the biotechnology sector with a market cap of $762.09 million. This commercial-stage company is driven by..

Evolus, Inc. (EOLS) Stock Analysis: Exploring a 202.30% Potential Upside

Evolus, Inc. (NASDAQ: EOLS), a healthcare firm entrenched in the specialty and generic drug manufacturing industry, is turning heads in the investor community with its significant..

Praxis Precision Medicines, Inc (PRAX) Investor Outlook: Analysts See 82% Upside Potential

Praxis Precision Medicines, Inc (NASDAQ: PRAX), a clinical-stage biopharmaceutical company at the forefront of developing therapies for central nervous system (CNS) disorders, has captured investor attention..

Trevi Therapeutics, Inc. (TRVI) Stock Analysis: A Biotech Gem with Over 107% Potential Upside

Trevi Therapeutics, Inc. (NASDAQ: TRVI) is making significant waves in the biotechnology sector, capturing the attention of investors seeking substantial growth potential. With a market capitalization..

Butterfly Network, Inc. (BFLY) Stock Analysis: Promising Growth in the Medical Devices Sector with a 23% Potential Upside

Butterfly Network, Inc. (NASDAQ: BFLY) is capturing attention in the healthcare sector with its innovative approach to ultrasound imaging. Specializing in handheld, smartphone-integrated ultrasound devices, the..

Fulgent Genetics, Inc. (FLGT) Stock Analysis: Exploring a Promising 11.65% Upside Potential

Fulgent Genetics, Inc. (NASDAQ: FLGT) is making waves in the healthcare sector, particularly within the Diagnostics & Research industry. With a market capitalization of approximately $694.52..

Geron Corporation (GERN) Stock Analysis: Unpacking the 160% Potential Upside in Biotech

Investors with an eye on the biotechnology sector may find Geron Corporation (NASDAQ: GERN) an intriguing option, particularly given its substantial potential upside. According to recent..

Anavex Life Sciences Corp. (AVXL) Stock Analysis: Exploring a Potential 260% Upside in the Biotechnology Sector

Anavex Life Sciences Corp. (NASDAQ: AVXL) is capturing the attention of investors with a remarkable potential upside of 260.64%, according to analyst target price projections. Operating..

Search

Funds

October 10, 2025

Search

Funds

October 10, 2025

FTSE 100

Funds